We are live on ! Find out more
AL

Arnhold LLC Portfolio holdings

AUM $1.36B
1-Year Est. Return 53.52%
This Fund
S&P 500
This Quarter Est. Return
-20.25%
1 Year Est. Return
+53.52%
3 Year Est. Return
+132.63%
5 Year Est. Return
+131.8%
10 Year Est. Return
AUM
$543M
AUM Growth
-$90.7M
Cap. Flow
+$80.2M
Cap. Flow %
14.78%
Top 10 Hldgs %
41.59%
Holding
147
New
24
Increased
39
Reduced
6
Closed
8

Top Buys

Rank Stock Value
1
XPO icon
XPO
XPO
+$9.68M
2
PFE icon
Pfizer
PFE
+$8.23M
3
PARA
Paramount Global Class B
PARA
+$7.16M
4
C icon
Citigroup
C
+$7.05M
5
GBDC icon
Golub Capital BDC
GBDC
+$6.96M

Sector Composition

Rank Sector Weight
1 Financials 14.27%
2 Healthcare 13.06%
3 Consumer Discretionary 12.76%
4 Technology 11.91%
5 Communication Services 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGLD icon
51
Royal Gold
RGLD
$17.1B
$2.28M 0.42%
26,040
PM icon
52
Philip Morris
PM
$301B
$2.18M 0.4%
29,850
OCSL icon
53
Oaktree Specialty Lending
OCSL
$1.03B
$2.14M 0.39%
220,180
+96,667
+78% +$1.41M
AMZN icon
54
Amazon
AMZN
$2.5T
$2.12M 0.39%
21,760
CMI icon
55
Cummins
CMI
$91.7B
$1.96M 0.36%
14,500
CBOE icon
56
Cboe Global Markets
CBOE
$29.8B
$1.96M 0.36%
21,935
BEN icon
57
Franklin Resources
BEN
$16.9B
$1.57M 0.29%
94,216
WIW
58
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$507M
$1.4M 0.26%
146,725
INTC icon
59
Intel
INTC
$466B
$1.38M 0.26%
25,571
LIN icon
60
Linde
LIN
$237B
$1.38M 0.26%
8,000
LBTYK icon
61
Liberty Global Class C
LBTYK
$3.27B
$1.36M 0.25%
86,910
NVS icon
62
Novartis
NVS
$295B
$1.31M 0.24%
15,848
ATR icon
63
AptarGroup
ATR
$8.45B
$1.29M 0.24%
12,939
M icon
64
Macy's
M
$6.15B
$1.24M 0.23%
252,867
-357,557
-59% -$4.85M
GNTX icon
65
Gentex
GNTX
$4.88B
$1.24M 0.23%
56,000
MRK icon
66
Merck
MRK
$324B
$1.23M 0.23%
16,812
MYN icon
67
BlackRock MuniYield New York Quality Fund
MYN
$374M
$1.23M 0.23%
100,600
IVAC
68
DELISTED
Intevac Inc
IVAC
$1.2M 0.22%
293,646
BNS icon
69
Scotiabank
BNS
$106B
$1.16M 0.21%
28,600
RY icon
70
Royal Bank of Canada
RY
$291B
$1.11M 0.21%
18,100
MNST icon
71
Monster Beverage
MNST
$91.4B
$1.11M 0.2%
39,300
CL icon
72
Colgate-Palmolive
CL
$72.6B
$1.07M 0.2%
16,200
PCH
73
DELISTED
PotlatchDeltic
PCH
$1.05M 0.19%
33,322
USB icon
74
US Bancorp
USB
$99.6B
$1.04M 0.19%
30,100
CGNX icon
75
Cognex
CGNX
$10.3B
$971K 0.18%
23,000

Similar funds

Arnhold LLC's Q1 2020 Portfolio in Review

As of Q1 2020, Arnhold LLC held 147 positions worth $543M, down 14% from $633M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Arnhold LLC deployed $80.2M of net new capital in Q1 2020, opening 24 new positions and adding to 39 existing holdings. Its largest new stake was XPO: 362,225 shares worth $6.11M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was AllianceBernstein Global High Income Fund, an estimated $8.1M trimmed.

  • Arnhold LLC's largest Q1 2020 buy was XPO: 362,225 shares worth $6.11M.
  • Arnhold LLC added most to Pfizer in Q1 2020, an estimated $8.23M increase.
  • Arnhold LLC's biggest Q1 2020 reduction was AllianceBernstein Global High Income Fund, cutting an estimated $8.1M.
  • Arnhold LLC fully exited Gilead Sciences in Q1 2020, selling an estimated $12.4M.
  • Arnhold LLC's ten largest holdings make up 42% of its $543M portfolio in Q1 2020.
  • Arnhold LLC opened 24 new positions and closed 8 in Q1 2020.
  • Arnhold LLC's portfolio value fell 14% quarter-over-quarter to $543M.

Based on Arnhold LLC's 13F filing for Q1 2020, filed 17 Apr 2020.